DIANA BAUTISTA: Open Payments
NPI 1699922997 · ORO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 14 payments from 8 companies in 2025. Trend: 2023 $349 · 2024 $236 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $602 |
| REVANCE THERAPEUTICS, INC. | 1 | $149 |
| Novo Nordisk Inc | 1 | $124 |
| Abbott Laboratories | 1 | $70 |
| Janssen Biotech, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: REZDIFFRA, DAXI, CARDIOMEMS, TREMFYA, OTEZLA, KISUNLA, MYFEMBREE.
Industry payments across AZ — which companies pay providers there.
